-
Something wrong with this record ?
Evaluation of potential aging biomarkers in healthy individuals: telomerase, AGEs, GDF11/15, sirtuin 1, NAD+, NLRP3, DNA/RNA damage, and klotho
P. Borsky, D. Holmannova, C. Andrys, J. Kremlacek, Z. Fiala, H. Parova, V. Rehacek, T. Svadlakova, S. Byma, O. Kucera, L. Borska
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
ProQuest Central
from 2000-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2000-01-01 to 1 year ago
- MeSH
- Biomarkers MeSH
- DNA MeSH
- Bone Morphogenetic Proteins MeSH
- Humans MeSH
- NAD * MeSH
- Glycation End Products, Advanced MeSH
- NLR Family, Pyrin Domain-Containing 3 Protein MeSH
- Growth Differentiation Factors metabolism MeSH
- Aged MeSH
- Sirtuin 1 MeSH
- Aging genetics MeSH
- Telomerase * MeSH
- Health Status MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Aging is a natural process of gradual decrease in physical and mental capacity. Biological age (accumulation of changes and damage) and chronological age (years lived) may differ. Biological age reflects the risk of various types of disease and death from any cause. We selected potential biomarkers of aging - telomerase, AGEs, GDF11 and 15 (growth differentiation factor 11/15), sirtuin 1, NAD+ (nicotinamide adenine dinucleotide), inflammasome NLRP3, DNA/RNA damage, and klotho to investigate changes in their levels depending on age and sex. We included 169 healthy volunteers and divided them into groups according to age (under 35; 35-50; over 50) and sex (male, female; male and female under 35; 35-50, over 50). Markers were analyzed using commercial ELISA kits. We found differences in values depending on age and gender. GDF15 increased with age (under 30 and 35-50 p < 0.002; 35-50 and over 50; p < 0.001; under 35 and over 50; p < 0.001) as well as GDF11 (35-50 and over 50; p < 0.03; under 35 and over 50; p < 0.02), AGEs (under 30 and 35-50; p < 0.005), NLRP3 (under 35 over 50; p < 0.03), sirtuin 1 (35-50 and over 50; p < 0.0001; under 35 and over 50; p < 0.004). AGEs and GDF11 differed between males and females. Correlations were identified between individual markers, markers and age, and markers and sex. Markers that reflect the progression of biological aging vary with age (GDF15, GDF11, AGEs, NLRP3, sirtuin) and sex (AGEs, GDF11). Their levels could be used in clinical practice, determining biological age, risk of age-related diseases and death of all-causes, and initiating or contraindicating a therapy in the elderly based on the patient's health status.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000531
- 003
- CZ-PrNML
- 005
- 20240213093233.0
- 007
- ta
- 008
- 240109s2023 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10522-023-10054-x $2 doi
- 035 __
- $a (PubMed)37523061
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Borsky, Pavel $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003, Hradec Kralove, Czech Republic
- 245 10
- $a Evaluation of potential aging biomarkers in healthy individuals: telomerase, AGEs, GDF11/15, sirtuin 1, NAD+, NLRP3, DNA/RNA damage, and klotho / $c P. Borsky, D. Holmannova, C. Andrys, J. Kremlacek, Z. Fiala, H. Parova, V. Rehacek, T. Svadlakova, S. Byma, O. Kucera, L. Borska
- 520 9_
- $a Aging is a natural process of gradual decrease in physical and mental capacity. Biological age (accumulation of changes and damage) and chronological age (years lived) may differ. Biological age reflects the risk of various types of disease and death from any cause. We selected potential biomarkers of aging - telomerase, AGEs, GDF11 and 15 (growth differentiation factor 11/15), sirtuin 1, NAD+ (nicotinamide adenine dinucleotide), inflammasome NLRP3, DNA/RNA damage, and klotho to investigate changes in their levels depending on age and sex. We included 169 healthy volunteers and divided them into groups according to age (under 35; 35-50; over 50) and sex (male, female; male and female under 35; 35-50, over 50). Markers were analyzed using commercial ELISA kits. We found differences in values depending on age and gender. GDF15 increased with age (under 30 and 35-50 p < 0.002; 35-50 and over 50; p < 0.001; under 35 and over 50; p < 0.001) as well as GDF11 (35-50 and over 50; p < 0.03; under 35 and over 50; p < 0.02), AGEs (under 30 and 35-50; p < 0.005), NLRP3 (under 35 over 50; p < 0.03), sirtuin 1 (35-50 and over 50; p < 0.0001; under 35 and over 50; p < 0.004). AGEs and GDF11 differed between males and females. Correlations were identified between individual markers, markers and age, and markers and sex. Markers that reflect the progression of biological aging vary with age (GDF15, GDF11, AGEs, NLRP3, sirtuin) and sex (AGEs, GDF11). Their levels could be used in clinical practice, determining biological age, risk of age-related diseases and death of all-causes, and initiating or contraindicating a therapy in the elderly based on the patient's health status.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a NAD $7 D009243
- 650 _2
- $a protein NLRP3 $7 D000071199
- 650 _2
- $a sirtuin 1 $7 D056564
- 650 12
- $a telomerasa $7 D019098
- 650 _2
- $a stárnutí $x genetika $7 D000375
- 650 _2
- $a růstové diferenciační faktory $x metabolismus $7 D055412
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a zdravotní stav $7 D006304
- 650 _2
- $a produkty pokročilé glykace $7 D017127
- 650 _2
- $a DNA $7 D004247
- 650 _2
- $a kostní morfogenetické proteiny $7 D019485
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Holmannova, Drahomira $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003, Hradec Kralove, Czech Republic. holmd9ar@lfhk.cuni.cz
- 700 1_
- $a Andrys, Ctirad $u Institute of Clinical Immunology and Allergology, University Hospital and Faculty of Medicine in Hradec Kralove, Charles University, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a Kremlacek, Jan $u Institute of Medical Biophysics, Faculty of Medicine in Hradec Kralove, Charles University, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a Fiala, Zdenek $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a Parova, Helena $u Institute of Clinical Biochemistry and Diagnostics, University Hospital and Faculty of Medicine in Hradec Kralove, Charles University, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a Rehacek, Vit $u Transfusion Center, University Hospital, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a Svadlakova, Tereza $u Institute of Clinical Immunology and Allergology, University Hospital and Faculty of Medicine in Hradec Kralove, Charles University, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a Byma, Svatopluk $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a Kucera, Otto $u Institute of Physiology, Faculty of Medicine in Hradec Kralove, Charles University, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a Borska, Lenka $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003, Hradec Kralove, Czech Republic
- 773 0_
- $w MED00007554 $t Biogerontology $x 1573-6768 $g Roč. 24, č. 6 (2023), s. 937-955
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37523061 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093230 $b ABA008
- 999 __
- $a ok $b bmc $g 2049281 $s 1210225
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 24 $c 6 $d 937-955 $e 20230731 $i 1573-6768 $m Biogerontology $n Biogerontology $x MED00007554
- LZP __
- $a Pubmed-20240109